医师报讯(融媒体记者 裘佳 黄玲玲)产超广谱β内酰胺酶肠杆菌目菌(ESBLs-PE)是当前全球面临的重要耐药问题之一,其最重要的耐药机制是产超 ...
Recently, antibacterial drugs against ESBL-producing Gram-negative bacteria accounted for ∼15% (2 out of 13) of all antibacterial drugs undergoing development in Phase II trials or later ...
Background: Infections caused by extended-spectrum β-lactamase (ESBL)–producing gram-negative organisms are a growing concern in hospitalized patients. Traditionally, these infections can be ...